Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label RCC. Show all posts
Showing posts with label RCC. Show all posts
Wednesday, August 29, 2012

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

›
RESULTS: In the Perifosine 228 trial, 1 patient achieved a partial response (objective response rate, 4%; 95% confidence interval, ...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.